Please use this identifier to cite or link to this item:
|Title:||Isolation and characterization of recombinant Brugian parasitic transglutaminase|
|Keywords:||adjuvants;filaricidals;immunoprophylaxis;molting;nematodes;protein disulphide isomerase;transgluta-minase;vaccine|
|IPC Code:||Int. Cl.8 C12N9/64|
|Abstract:||An attempt has been made to identify and characterize a putative chemotherapeutic target antigen for human lymphatic filariasis by recombinant DNA techniques. Identification of transglutaminase (TGA), an enzyme vital for the growth and survival of the parasites, has opened a new drug target for developing potent therapeutic agents against the parasites. TGA gene from Brugia malayi adult female parasite (BmTGA) has been subcloned, expressed and purified as a 47 kDa fusion protein with N-terminal histidine tag. Since BmTGA lacks homology to mammalian TGAs, it is a promising drug target for developing chemotherapeutic agent and candidate vaccine against human lymphatic filariasis.|
|ISSN:||0975-0967 (Online); 0972-5849 (Print)|
|Appears in Collections:||IJBT Vol.05(3) [July 2006]|
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.